Streetbeat News

Regulatory

TSLA

Tesla shares are trading lower due to an NTSB investigation into a Tesla Semi crash and delays in the Full Self-Driving technology for the Cybertruck. The stock has been fluctuating between $210 and $230, with mixed investor sentiment.

Portfolio Pulse from Vaishali Prayag

August 22, 2024 | 7:38 pm

BTCUSD

ETHUSD

Speculation is rising about a potential interest rate cut by the Federal Reserve in September 2024, with significant implications for both traditional and cryptocurrency markets. Polymarket data shows a 75% chance of a 25 bps rate cut, which could increase liquidity and risk appetite, benefiting cryptocurrencies like Bitcoin and Ethereum.

Portfolio Pulse from Murtuza Merchant

August 22, 2024 | 7:18 pm

BMY

Bristol-Myers Squibb announced that the FDA has scheduled an Oncologic Drugs Advisory Committee meeting for September 26 to discuss PD-L1 expression levels in gastric and esophageal cancers.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 7:08 pm

RTX

The U.S. State Department has approved a potential $592 million sale of Advanced Medium-Range Air-To-Air Missiles (AMRAAM) to Romania. This deal involves RTX Corporation, which is likely to supply these missiles.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 7:08 pm

NVAX

Novavax shares declined after the FDA excluded the company from its latest updates on emergency use authorization for vaccines.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 7:03 pm

SCHW

TD

Charles Schwab shares are declining after TD Bank sold 40.50 million shares, reducing its stake from 12.3% to 10.1%. This sale is linked to TD Bank's anticipation of penalties from U.S. regulatory probes related to anti-money laundering deficiencies.

Portfolio Pulse from Dylan Berman

August 22, 2024 | 6:48 pm

TSLA

Tesla shares are declining following the announcement of a delay in the Cybertruck's full self-driving rollout and an investigation by the National Transportation Safety Board into a Tesla vehicle crash.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:42 pm

BNTX

MRNA

NVAX

PFE

The FDA has approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna, targeting the Omicron variant KP.2 strain. Novavax's vaccine was not included in this approval. The updated vaccines are expected to be available soon, with Pfizer and Moderna stocks experiencing a decline following the news.

Portfolio Pulse from Vandana Singh

August 22, 2024 | 6:33 pm

NUWE

Nuwellis has filed a new patent application for an 'Extracorporeal Blood Filtering Machine and Methods for Renal Replacement Therapy'. This development could enhance their product offerings in the medical device sector.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:30 pm

AMZN

DIS

NFLX

SONY

The $8.5 billion merger between Walt Disney Co. and India's Reliance Industries media assets faces antitrust concerns from the Indian regulator over cricket broadcasting rights. The companies are exploring remedies but are reluctant to part with these rights, which are crucial for the merger's success.

Portfolio Pulse from Vandana Singh

August 22, 2024 | 6:16 pm